26.31
Quidelortho Corporation stock is traded at $26.31, with a volume of 1.08M.
It is down -0.23% in the last 24 hours and down -7.91% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
See More
Previous Close:
$26.37
Open:
$26.77
24h Volume:
1.08M
Relative Volume:
0.80
Market Cap:
$1.79B
Revenue:
$2.74B
Net Income/Loss:
$-441.40M
P/E Ratio:
-4.0229
EPS:
-6.54
Net Cash Flow:
$13.00M
1W Performance:
-11.11%
1M Performance:
-7.91%
6M Performance:
-2.23%
1Y Performance:
-35.91%
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
QDEL
Quidelortho Corporation
|
26.31 | 1.79B | 2.74B | -441.40M | 13.00M | -6.54 |
![]()
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
May-08-25 | Upgrade | Jefferies | Hold → Buy |
Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
Dec-10-24 | Initiated | Jefferies | Hold |
Sep-19-24 | Resumed | UBS | Neutral |
Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
Mar-04-24 | Downgrade | UBS | Neutral → Sell |
Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
Oct-14-22 | Upgrade | UBS | Sell → Neutral |
Sep-19-22 | Initiated | Citigroup | Neutral |
Jul-20-22 | Initiated | UBS | Sell |
Jun-17-22 | Resumed | JP Morgan | Neutral |
Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
Oct-23-18 | Resumed | Raymond James | Strong Buy |
Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
Jan-22-18 | Reiterated | Barclays | Overweight |
Jan-04-18 | Upgrade | CL King | Neutral → Buy |
Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
Feb-17-17 | Initiated | CL King | Neutral |
Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
Feb-18-16 | Reiterated | Barclays | Overweight |
Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
Sep-02-15 | Initiated | Barclays | Overweight |
Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
What MACD signals say about QuidelOrtho CorporationJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com
Leading vs lagging indicators on QuidelOrtho Corporation performanceMarket Risk Analysis & High Return Stock Watch Alerts - newser.com
Will QuidelOrtho Corporation stock recover faster than market2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Will QuidelOrtho Corporation stock benefit from infrastructure spendingEarnings Risk Summary & Reliable Price Breakout Signals - newser.com
How to read the order book for QuidelOrtho CorporationTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
Will QuidelOrtho’s (QDEL) Slower Growth Shift the Long-Term Innovation Story? - simplywall.st
William Blair Has Weak Estimate for QuidelOrtho Q2 Earnings - MarketBeat
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know - Yahoo Finance
What’s the recovery path for long term holders of QuidelOrtho Corporation2025 Trading Recap & Weekly Watchlist for Hot Stocks - newser.com
Using fundamentals and technicals on QuidelOrtho CorporationTreasury Yields & Fast Moving Stock Trade Plans - newser.com
How QuidelOrtho Corporation stock trades during market volatilityEarnings Beat & Low Drawdown Investment Strategies - newser.com
Visualizing QuidelOrtho Corporation stock with heatmaps2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Backtesting results for QuidelOrtho Corporation trading strategiesStop Loss & Capital Efficient Trade Techniques - newser.com
QuidelOrtho (QDEL): Exploring Valuation After Analyst Downgrade and Weaker Growth Outlook - Yahoo Finance
Is QuidelOrtho Corporation QL1A a good long term investmentHigh Yield Income Stocks & Start Small. End Wealthy. - earlytimes.in
QuidelOrtho Hold Rating: Impact of Debt Refinancing and Chinese Market Risks - TipRanks
Gagnon Securities LLC Has $2.10 Million Stock Holdings in QuidelOrtho Corporation $QDEL - MarketBeat
QuidelOrtho Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
QuidelOrtho (NASDAQ:QDEL) Shares Gap DownHere's What Happened - MarketBeat
Why QuidelOrtho (QDEL) Stock Is Down Today - TradingView
Citigroup Downgrades QuidelOrtho to Neutral From Buy, Adjusts Price Target to $33 From $40 - MarketScreener
Exploring QuidelOrtho (QDEL) Valuation as Shares Decline 6% to Close at $29.98 - simplywall.st
What sentiment indicators say about QuidelOrtho Corporation stockLong Setup & Technical Entry and Exit Alerts - newser.com
Why QuidelOrtho Corporation (QL1A) stock could be next leaderWeekly Gains Summary & High Win Rate Trade Alerts - newser.com
Will QuidelOrtho Corporation (QL1A) stock keep raising dividends2025 Market Trends & Detailed Earnings Play Alerts - newser.com
Will QuidelOrtho Corporation continue its uptrend2025 Market WrapUp & Precise Buy Zone Identification - newser.com
Does QuidelOrtho Corporation show high probability of reboundChart Signals & Free Fast Gain Swing Trade Alerts - newser.com
How QuidelOrtho Corporation (QL1A) stock behaves under inflation pressureTrade Performance Summary & Community Verified Watchlist Alerts - newser.com
Long term hold vs stop loss in QuidelOrtho CorporationMarket Activity Recap & AI Optimized Trade Strategies - newser.com
Will QuidelOrtho Corporation bounce back from current supportWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Will QuidelOrtho’s (QDEL) Rapid Respiratory Test Raise Its Profile in Point-of-Care Diagnostics? - simplywall.st
QuidelOrtho Corporation $QDEL Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Trading Down 5.5%What's Next? - MarketBeat
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know - TradingView
QuidelOrtho launches QUICKVUE Influenza + SARS Test - SelectScience
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):